|
Tabla 1: Proporciones agrupadas de resistencia a los antibióticos para Klebsiella pneumoniae. |
||||||
|
Resistencia % |
General N = 1,088 n (%) |
2020 N = 187 n (%) |
2021 N = 248 n (%) |
2022 N = 270 n (%) |
2023 N = 241 n (%) |
2024 N = 142 n (%) |
|
Ampicilina- sulbactam |
665 (61.1) |
123 (65.8) |
170 (68.5) |
122 (45.2) |
154 (63.9) |
96 (67.6) |
|
Amoxicilina- ácido clavulánico |
700 (64.3) |
122 (65.2) |
168 (67.7) |
165 (61.1) |
155 (64.3) |
90 (63.4) |
|
Ceftriaxona |
673 (61.9) |
125 (66.8) |
163 (65.7) |
130 (48.1) |
162 (67.2) |
93 (65.5) |
|
Cefotaxima |
770 (70.8) |
129 (69.0) |
202 (81.5) |
139 (51.5) |
188 (78.0) |
112 (78.9) |
|
Ciprofloxacino |
731 (67.2) |
146 (78.1) |
199 (80.2) |
140 (51.9) |
158 (65.6) |
88 (62.0) |
|
Gentamicina |
395 (36.3) |
64 (34.2) |
90 (36.3) |
65 (24.1) |
106 (44.0) |
70 (49.3) |
|
Levofloxacino |
1,085 (99.7) |
186 (99.5) |
248 (100.0) |
270 (100.0) |
241 (100.0) |
140 (98.6) |
|
Piperacilina- tazobactam |
370 (34) |
51 (27.3) |
73 (29.4) |
90 (33.3) |
84 (34.9) |
72 (50.7) |
|
Trimetoprima sulfametoxazol |
570 (52.4) |
95 (50.8) |
133 (53.6) |
108 (40.0) |
149 (61.8) |
85 (59.9) |
|
Amikacina |
489 (44.9) |
112 (59.9) |
109 (44.0) |
91 (33.7) |
111 (46.1) |
66 (46.5) |
|
Cefepima |
505 (46.4) |
115 (61.5) |
114 (46.0) |
79 (29.3) |
115 (47.7) |
82 (57.7) |
|
Cefuroxima |
561 (53.4) |
121 (64.7) |
158 (63.7) |
109 (40.4) |
132 (54.8) |
61 (430) |
|
Ertapenem |
73 (6.7) |
15 (8.0) |
13 (5.2) |
7 (2.6) |
21 (8.7) |
17 (12.0) |
|
Imipenem |
56 (5.1) |
13 (7.0) |
9 (3.6) |
11 (4.1) |
14 (5.8) |
9 (6.3) |
|
Meropenem |
74 (6.8) |
15 (8.0) |
12 (4.8) |
12 (4.4) |
20 (8.3) |
15 (10.6) |
|
Tetraciclina |
571 (52.5) |
100 (53.5) |
134 (54.0) |
156 (57.8) |
114 (47.3) |
67 (47.2) |
|
Tobramicina |
1,068 (98.2) |
187 (100.0) |
248 (100.0) |
270 (100) |
234 (97.1) |
129 (90.8) |
|
Ceftazidima |
587 (54.0) |
115 (61.5) |
137 (55.2) |
116 (43.0) |
128 (53.1) |
91 (64.1) |